Shortcuts: Picking Stocks That Don?t Sin Socially responsible investing can mean pursuing psychic as well as financial rewards.... Read Full Article Intel Earnings Exceed Expectations The chip maker, a closely watched indicator of the overall health of the technology industry, reported net income of $1.3 billion, on revenue of $8.7 billion in the second quarter.... Read Full Article Exports Seen As Key Driver For Economy Growth in the manufacturing sector slowed in August while construction spending dropped sharply in July, data showed.... Read Full Article Letterman Sides With Hollywood Writers As Strike Looms The veteran American broadcaster David Letterman used his prime-time show to speak out in support of Hollywood writers poised to go on strike, a move which could take some of the country’s most ... Read Full Article Square Feet | Ventures: At Headquarters, Shoes Are The Showcase A move downtown finally gave the Nina Footwear Corporation the room it needed to efficiently manage its $150-million-a-year business.... Read Full Article |
World Business Briefing | Europe: Germany: Bid To Acquire Drug Maker’s Generic UnitAn Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Mercks generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt. Tag CloudExternal InformationAdditional InformationWhen Opportunity Came Crawling...Europe’s Next Rate Move May Be an Increase... Profit Up 64% at Kimberly-Clark... Small Shops See Smallness as Their Big Selling Point... Where Am I?News Main Page - Business - World Business Briefing | Europe: Germany: Bid To Acquire Drug Maker’s Generic Unit |
i8news.com |